Mantle cell lymphoma interventions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mantle cell lymphoma}} | {{Mantle cell lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Akram}} | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for | The mainstay of treatment for mantle cell lymphoma is [[medical]] [[therapy]]. | ||
==Indications== | ==Indications== | ||
The mainstay of treatment for | The mainstay of treatment for mantle cell lymphoma is [[medical]] [[therapy]]. | ||
==References== | ==References== |
Latest revision as of 20:22, 7 January 2019
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma interventions On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma interventions |
Risk calculators and risk factors for Mantle cell lymphoma interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2]
Overview
The mainstay of treatment for mantle cell lymphoma is medical therapy.
Indications
The mainstay of treatment for mantle cell lymphoma is medical therapy.